Marina has extensive experience in GMP production of cell culture, development of cell treatment processes and scale-up. She has 10+ years of hands-on experience in 2D and 3D cell expansion. Most recently, Marina was a process engineer at Pluri Inc. (Nasdaq:PLUR), a cell therapy development company, where she improved cell culture growth processes and transferred technology from development to GMP production.